Evidence map›Paper›PMID 33333817›Full record

ArticlePharmaceuticals (Basel, Switzerland)2020

In Vitro Bioassay-Guided Identification of Anticancer Properties from

Prapakorn Wisitpongpun, Nungruthai Suphrom, Pachuen Potup, Nitra Nuengchamnong, Philip C Calder, Kanchana Usuwanthim

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Anti-Fibrotic Effect of Oleamide Identified from theInternational journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  13. Article
  14. Article
  15. Formulation, Optimization, and Evaluation ofMolecules (Basel, Switzerland) · 2022
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Prapakorn WisitpongpunCellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Nungruthai SuphromDepartment of Chemistry, Faculty of Science and Center of Excellence for Innovation in Chemistry, Naresuan University, Phitsanulok 65000, Thailand.
Pachuen PotupCellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Nitra NuengchamnongScience Laboratory Centre, Faculty of Science, Naresuan University, Phitsanulok 65000, Thailand.
Philip C CalderSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.ORCID 0000-0002-6038-710X
Kanchana UsuwanthimCellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.ORCID 0000-0002-4039-5882

Funding

Royal Golden Jubilee Ph.D. Program PHD/0002/2559TRF Research Career Development Grant RSA6080042
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

1-phenyl-2-pentanol7-octenoic acidLC-ESI-QTOF-MS/MSMDA-MB-231Moringa oleiferaoleamidetriple negative breast cancer

Identifiers

PMID33333817
PMCPMC7765196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.